The Eradigm team is made up of a group of highly motivated, experienced professional consultants who come from a diverse range of backgrounds. Our vast collective experience spans all aspects of pharma, biotech and life sciences and has been gained addressing the most complex strategic challenges for the most demanding of organisations. Each of our client teams are led by a senior consultant, with a partner involved on every brief that we address.
Partners and Directors
With a career in consulting spanning almost 15 years, Patrick cares deeply about helping clients crystallise complex multi-component strategic challenges at all stages of the product and company lifecycle. His clients include multinational manufacturers of cutting-edge and mature biopharmaceuticals, vaccines and medical technologies. Patrick is inquisitive and thought provoking, leveraging his broad experience to help drive smarter, more holistic strategies tapping into subtle sources of competitive advantage. His work cuts across and unites internal functional areas, building consensus within organizations around the business case for transformational initiatives, developing and communicating the evidence architecture for diverse teams to take bold decisions with confidence.
As a founding partner of Eradigm, Patrick plays a critical role in shaping the culture of the business, working closely within the team to cultivate a passion for unparalleled excellence, and a learning environment in which consultants can push themselves towards being among the biopharmaceutical industry’s very best strategic minds. He is passionate about nurturing raw, world class consulting talent. Patrick is a visiting lecturer on various graduate programmes spanning Innovation, Entrepreneurship and Biopharma Business Strategy at the University of Cambridge and at Imperial College London.
Prior to founding Eradigm, Patrick spent the best part of a decade building a global strategy consultancy. In a former life, he was a globetrotting biochemist, latterly working at the University of California Berkeley, and the Tokyo Institute of Technology. He holds a BSc. in Biology from the University of Bristol, a Masters from the University of York and a PhD from the University of Sheffield. A keen linguist, Patrick speaks fluent French, Italian and Izakaya level Japanese.
Patrick spends his personal time with his wife and three young children, bouncing around the South East of the UK coordinating tennis, swimming, climbing, piano, ballet and numerous other after school activities. When he has a few seconds to himself, he can be found at his local triathlon club, churning out the meters in the pool or reservoir, or pounding the footpaths of the British countryside on long distance runs. Patrick has completed multiple marathons and ultramarathons and one day once the kids have fled the nest, will aim to traverse Asia on his adventure motorbike and explore every gastronomic corner of Italy.
Learn more about Patrick and the journey to Eradigm
The EMG GOLD Podcast aims to provoke conversations with stakeholders in the pharmaceutical industry, reports on the latest trends and innovations, and shares insight from high-profile guests. In this 2020 Podcast, Patrick Romano provided more insights into his career to date and how this shaped his thinking around Eradigm’s offering.
https://www.emg-health.com/omnipresent/?category=podcasts/
Marcus is respected for taking a no-nonsense approach throughout his 20 years in life sciences. With experience in the trenches of strategic marketing, market access, product launch and competitive strategy, Marcus can see the wood from the trees – which is often half the battle in our increasingly complex stakeholder environment.
When technology is poised to make material differences to the very value proposition that pharmaceutical companies offer, when new themes are emerging from preventative care to consumerisation to digital drug design, only a handful people are able to cut through the hype and establish what is important. Marcus’ brand of thoughtful yet straightforward leadership is what clients and colleagues rely on to see through to the other side – and understand where resources should be invested today.
Marcus was previously Principal at Deallus Consulting, Global Vice President at Voisin Consulting and European Vice President at GfK Bridgehead. In these positions he built multiple expert teams of consultants providing market insights, launch readiness and lifecycle management support for global biopharmaceutical clients. He also played a key role in helping Deallus redefine their company growth strategy after a private equity acquisition.
Prior to that he had a number of global roles in market access, launch strategy, marketing and brand management at companies including Novartis, Eisai and Takeda. In every instance, he was able to harmonise and refocus teams around what really mattered for better performance.
As co-founding partner of Eradigm, Marcus’ simple philosophy, which he ensures is ingrained within the fabric of Eradigm, is ‘consult first, strive for excellence and deliver uncomplicated quality’.
Marcus spends his personal time with his family, generally trying (and failing) to avoid being a taxi-service for his 2 children (football, rugby, piano, swimming etc etc….) and attempts to live his life by 3 simple rules: 1. Make time. 2. Read more and scroll less and 3. If you don’t like something, change it. If you can’t change it, change your attitude…
Javier rejoined Eradigm as a Director in April 2025, with a longstanding career across both Competitive Intelligence and Strategy consulting.
Prior to his return, he had been part of the senior leadership teams at IPG Health Consulting and Vintura; boutique Life Sciences consultancies where he led the UK consulting business, championed the early commercialisation value proposition and delivered work across competitive strategy, commercial strategy, and market access with Big Pharma and Biotechs in both the US and EU.
Before this, Javier was a core member of the Eradigm’s growth for over 3 years and brings a prior foundation in both Biochemical Engineering (MEng) and management consulting at PA Consulting.
He has worked across a number of therapeutic areas, with particular focus in rare diseases, oncology & haematology, immunology and novel platforms such as cell & gene therapies and AI.
Outside of work he is an avid traveller, having just completed a world tour to over 20 countries, and a keen musical theatre enthusiast, for which being based in central London has certainly paid off.
David rejoined Eradigm as a Director in April 2025, building on his earlier contributions since 2020 as a key driver of the firm’s delivery excellence.
He holds a PhD in DNA Repair and Radiotherapy from the Institute of Cancer Research, where his research focused on uncovering the molecular drivers of fraction size sensitivity. He also earned an MSci in Genetics from University College London, specialising in the biology of ageing. David brings deep scientific expertise across oncology, infectious diseases, and immunology.
David is known for his strategic clarity and ability to guide clients through complex decision-making, delivering measurable impact across global projects. With a strong foundation in competitive intelligence (CI) methodologies, he designs and leads projects that effectively bridge CI and strategy. His insights are shaped by extensive industry experience across all levels—from individual products to cross-portfolio and corporate strategy—enhanced by a solid grounding in market access.
David’s approach to leadership and mentorship is defined by analytical rigour, curiosity, and a collaborative spirit that aligns with Eradigm’s ethos.
Outside of work, David is a passionate athlete, competing internationally in Canoe Polo, a fast-paced five-a-side kayaking sport. He also enjoys combining his love of travel and conservation through amateur wildlife photography.
Managers and Consultants
Louise rejoined Eradigm after serving as Head of Solutions at a clinical trial technology startup, where he helped develop and operationalize a digital platform to streamline end-to-end clinical trial delivery for biopharma sponsors. His work enabled faster, more reliable, and patient-centric trials, supporting the efficient development of new therapeutics.
At Eradigm, Louise has delivered strategic projects for global pharmaceutical clients across cardiovascular, renal, and metabolic disorders (CVRM), immunology, haematology-oncology, and rare diseases. His experience includes competitive intelligence, product launch readiness, market sequencing, value and access strategy, and integrated evidence planning. He is particularly skilled at aligning clinical development strategies with evolving market and access landscapes.
Louise holds an MPhil in Bioscience Enterprise from the University of Cambridge, where he worked with emerging life science companies on commercialization and product development. He also holds a BSc in Molecular Biology and Biotechnology and a Masters in Technology Management from the University of the Philippines, where he worked on the development of anti-pain drug candidates from conotoxin peptides.
In his free time, Louise enjoys tinkering with retro gaming consoles, creating digital artwork, and playing basketball.
Brynna joined Eradigm in July 2021 as an Associate Consultant, bringing extensive experience in biomedical research and a passion for global healthcare.
She holds a PhD in Cancer Biology from Barts Cancer Institute in London, part of Barts and the London School of Medicine and Dentistry. Her research was funded by the Biotechnology and Biological Sciences Research Council and focused on using technology to answer biological questions. There she was part of a multidisciplinary team of biologists and engineers, working to characterise and target a newly identified lung cancer driver mutation, and identify novel therapeutic strategies to treat it.
After completing her PhD, Brynna was awarded a grant to continue her research at Barts Cancer Institute as a postdoctoral researcher, and begin translating her research in the clinical sphere.
Prior to her academic studies, Brynna also worked in global health, where she developed tailored solutions to meet the needs of rural communities in Madagascar. There she led an initiative to improve public and environmental health through sustainable economic growth.
Outside of work, Brynna loves trying new and delicious food, as long as she doesn’t have to do the cooking. She is also an avid reader, loves taking on new knitting projects, and is learning to play the piano.
Focus Therapy Areas: Oncology (Solid Tumors & Hematology), Rare Disease, Cardiovascular
Specialist Expertise: Pricing and Market Access Strategy, Landscape Assessments, Market Insights
Education: BEng Mechanical Engineering, McGill University; MScEng Biomedical Engineering, Imperial College London
What is your focus at Eradigm?
At Eradigm, I bring a strong analytical background and understanding of global strategy, access, and pricing dynamics. My focus delivering targeted and impactful insights and recommendations to clients through high quality research and a collaborative engagement approach
Who do you work with?
I typically collaborate with global commercial and access teams, from both top 10-pharma and small to mid-size biotech companies.
What is your specialist expertise, and what types of projects do you work on?
My expertise lies in achieving developing strategic solutions to address business needs across broad therapeutic areas and geographical regions. I work across different project types delivering impactful market insights, commercial strategy recommendations, and understanding various pricing and reimbursement challenges in key geographies including the EU and Japan. Key capabilities include global primary research experience with payers and stakeholders, as well as secondaryresearch based landscape mapping in oncology, giving strategic support to clients across the product development lifecycle
What did you do before Eradigm?
Prior to Eradigm, I completed my MScEng degree in Biomedical Engineering completing a year-long research project working with a multidisciplinary team of doctors and engineers to build computational models that simulate and predict the development of congenital heart diseases in fetuses
What are your passions outside of work?
Outside of studies and work, I participated in several medical mission trips to rural and underserved communities in Haiti, Jamaica, India, and Brazil; experiences which have given me the motivation to make an impact on society through the biopharma industry. In my spare time, I love to travel, read and watch old movies
YanWen brings with her a breadth of healthcare, research, and management consulting experience as she joins Eradigm in April 2022. Her previous professional experience includes strategy and operations consulting in PricewaterhouseCoopers as well as drug re-purposing research in a joint Masters’ project between UCL and Hanyang University of South Korea. Her previous consulting experience includes delivering and supporting work in:
Pharmaceutical & Life Sciences: Cost-to-serve, customer service models, market access, regulatory and reimbursement, digital operations, and commercialisation strategies with global PharmaCos and Medtech clients.
Healthcare: Strategy development, strategic option appraisals, benefits costing, operating model design, and system level sustainability plan development with NHS Trusts and Integrated Care Boards.
In building a cross-functional, broad therapeutic portfolio and having a strong person-centric health and care foundation, YanWen hopes to deliver meaningful strategic insights and recommendations that will make a difference.
Outside of work, YanWen loves being active and exploring the city by foot, being a wannabe foodie, and planning her next adventure. Her curiosity in all things DIY and love for socialising means lots of crafty projects (they make for cozy events – pumpkin carving? wreath making? #yes). And of course, she enjoys a good pint or a cheeky cocktail while engaging in conversations about the meaning of life!
Barney joined Eradigm in January 2022 as an Associate Consultant, bringing an experience in bioscience research and a passion for improving global healthcare.
He holds a PhD in Interdisciplinary Bioscience from the University of Oxford, which formed part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Barney’s work focused on combining biocatalysts with continuous flow technology to improve the sustainable synthesis of pharmaceutical compounds. He was part of a team of chemists, biologists and engineers who worked to develop this biotechnology and successfully spin-out a company. In recognition of his work on this project, Barney was awarded a commendation in Enterprise and Innovation at the University of Oxford Bioscience Impact Awards.
As part of his PhD, Barney undertook a work placement at a large generics company. As part of the team, Barney applied the processes that he had developed in the academic laboratory to industrially relevant chemical transformations.
Barney completed his formative academic studies at the University of Warwick, graduating with an MChem in Chemistry with Professional Experience. His dissertation focused on performing enantioselective synthesis using novel organocatalysts. During his third year of study, Barney undertook a four-month placement at Monash University, Australia, which ignited his passion for academic research.
Outside of his work, Barney is a keen sportsman, who has played football at university level. He continues to enjoy many other sports, including cricket, golf, and squash, and finds pleasure in cooking, having a particular love for Indian and Italian cuisine. An inherited passion for music took hold during his younger years, growing up in Cornwall, at which time he travelled with local orchestras to perform in locations as far afield as San Francisco.
Nadeen joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her extensive experience in genetic engineering and cancer research, and everlasting passion for the Life Sciences industry.
Nadeen holds a PhD in Molecular Biology & Biochemistry from the University of Westminster, where her work focused on the molecular characterisation a novel cancer driver gene in replication stress-induced genomic instability using CRISPR/Cas-based human cellular models, in collaboration with the Francis Crick Institute and the University of Zurich. During the pursuit of her doctorate, Nadeen was awarded research grants to support the clinical translation of genetically-engineered human cellular models to commercial products, in collaboration with renowned Life Science industries. Nadeen was also heavily involved in the co-design and mentorship of IBMS-accredited CRISPR/Cas-based workshops where she was consulted for her technical expertise on the use and applications of the cutting-edge technology.
Alongside her PhD studies, Nadeen acquired a professional development qualification in learning and teaching within the Higher Education Academy, U.K., and held a Visiting Lectureship position in Life Sciences at the University of Westminster for over three years. She also has experience in working as a Molecular Biologist at Health Services Laboratories (HSL) where she acquired extensive knowledge on the evolving clinical diagnostic landscape.
Outside of work, Nadeen is a curious soul who enjoys meeting new people and visiting new places. In her spare time, Nadeen enjoys salsa dancing as well as fitness through the practice of kickboxing, running and Pilates. She also enjoys reading on Science-related subjects and self-development, and whenever she gets the opportunity, she loves to travel and explore new cultures.
Oliver holds a PhD in Nutrition and Human Metabolism from the University of Birmingham, which was part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Oliver’s work focused on dairy nutrition, specifically trying to understand the metabolism of the milk sugar lactose in humans, to try to identify new applications for this low value, side stream product of the dairy industry. He has run human volunteer studies, in university laboratory and hospital settings across the country. He is interested in the intersection of nutrition and other modifiable lifestyle factors and healthcare, as well as life sciences and health more broadly.
Oliver also spent time working with the industrial partner of his PhD, a major European dairy ingredients company. He ran a market research project into consumer habits to identify gaps in product offerings and nominate new ingredients and products for development. This built on his previous experience in market research, throughout his undergraduate degree at the University of Exeter. Throughout his PhD, Oliver taught undergraduates extensively, from lecturing to running laboratory sessions. He particularly enjoyed the process of breaking down complex topics and explaining them to students. He is also an Associate Fellow of the Higher Education Academy.
Oliver is a passionate scuba diver, having recently completed his rescue diver qualification, he has dived extensively in Europe, Asia and Africa. Oliver is also a competitive powerlifter in his free time though has a keen interest in other strength sports. Throughout 2021 he volunteered with St John Ambulance to assist with the vaccine rollout, administering vaccines and helping to organise the day to day running vaccine centres.
Shreya joined Eradigm in April 2021 as an Associate Consultant. With a keen interest in novel therapeutic strategies, Shreya brings her experience in biomedical research and knowledge of the pharmaceutical industry to the team.
Shreya achieved her Master’s in Novel Therapies- Genes, Drugs and Stem Cells at Imperial College London where she took a multidisciplinary approach to understanding gene therapies, regenerative medicine, and the drug development process. For her master’s thesis, she worked on the optimization of synthetic mRNA for therapeutic use in airway epithelial cells. Prior to this, she completed her Bachelor’s degree in Genetics from the University of Sussex where she carried out research investigating the relationship between the structure and stability of DNA replication checkpoint proteins.
Alongside her academics, Shreya worked on an investment management start-up specializing in digital assets. This venture stimulated her ambition to apply her experience in life sciences in a more strategic business environment. She is also a huge believer in increasing the accessibility of education and has spent a year as a volunteer teacher, tutoring underprivileged kids in shelter homes in mathematics and science.
In her free time, Shreya enjoys exploring new restaurants, going to the cinema, and hiking. She summited Mt Kilimanjaro in 2018 to fundraise for clean water and sanitation and aims to summit Mt Everest by 2026.
Jessica holds a PhD in Cancer Epigenetic Epidemiology from Newcastle University, her project focused on DNA methylation as a potential mediator of early life exposures and the risk of childhood acute lymphoblastic leukaemia (ALL). During her PhD, she worked both in the laboratory and carried out computational analyses, collaborating with different faculties within Newcastle University and Bristol University. Throughout her PhD and post-doc position, Jessica taught molecular, genetic, epigenetic, and epidemiological modules on MSc courses at Newcastle University and supervised and assessed undergraduate/postgraduate students. Additionally, Jessica spent 3 years as a post-doctoral researcher at King’s College London, where her focus was in immune-oncology and computational biology, projects included exploring immune regulation and dysregulation in myeloproliferative neoplasms and myelodysplastic syndromes; and COVID-19 patient immune response to Baricitinib: can we predict immune dysregulation?
Since moving into life sciences consulting, Jessica has been part of, and led a variety of projects, mostly focused on oncology (both heme and solid tumours). Her experience includes data collection and interpretation, designing deliverables, leading client updates, deep-dives, attending conferences, delivering ad-hoc requests, and conducting comprehensive and robust primary and secondary market research. Experience in compiling competitive intelligence for novel therapeutics, including a thorough assessment of the commercial landscape, unmet needs, and market positioning. Additionally, Jessica has designed and run workshops to help clients understand competitors, pressure test assumptions, and gain deeper insight into the scientific aspects of their projects. Jessica has experience with healthcare systems in multiple geographies, including the US and EU.
Outside of work, Jessica loves to explore, whether it is a different country and culture or different parts of the UK, especially trekking through beautiful landscapes. Jessica is also a huge lover of music and spends a lot of time at gigs, events, or festivals.
Kamaal Joins Eradigm as an associate consultant bringing experience in psychiatric disorder treatment research and a desire to improve drug discovery pipelines.
He holds a BSc in Pharmacology from UCL where his passion for the translation of preclinical research to life-changing clinical therapies was initiated. During his degree, he conducted a research project where he screened BK channel activating drugs on the voltage dependence of BK channels using patch-clamp techniques. He was part of a team of pharmacologists and bioscientists investigating these BK channel properties for insights into respiratory diseases and potential treatments.
During his studies, Kamaal worked as a Covid-19 testing assistant in the UCL testing site where he gained a unique first-hand perspective of the impact of the global pandemic.
In between his studies, Kamaal solely produced and released a report on the most novel antidepressant and anxiolytic drugs in phase II clinical trials or later for the mental health charity Overcome, as an intern. This report was a part of the charity’s initiatives focused on providing accessible and free solutions globally for psychiatric disorders. As a business development intern for FlowCell Kamaal got to grips with the needs of end-users in the neuroscience field by liaising with potential clients to build customer profiles.
Outside of work, Kamaal is a keen fitness enthusiast playing American football competitively and being an avid gym-goer. He has a passion for Sci-Fi/fantasy books and films with his current favourite being the Dune book series by Frank Herbert due to its expansive story and philosophical overtones.
Isaac joined Eradigm as an Associate Consultant in September 2022, bringing with him a breadth of experience working in pharmaceutical market research.
In his previous role, Isaac focused on conducting primary and secondary quantitative research, in order to provide actionable insights that would answer clients research needs and objectives. Isaac has experience utilising a wide array of complex research methodologies and working with some of the largest pharmaceutical companies around the world. It was during this time that he developed a real passion for global healthcare.
Isaac holds a Bsc in Psychology from the University of Manchester through which helped him gain extensive knowledge in areas such as behavioural psychology, cognitive neuroscience, quantitative research methodologies, and statistics and data analysis. For his dissertation he carried out his own research study, investigating the effects of loss aversion on visual extrapolation under risk.
Outside of work, Isaac is a big sports enthusiast with a particular passion for football, going to the gym and skiing. However Isaac is also big into his travel, music and cooking.
Senior Associate and Associate Consultants
Nephelie joined Eradigm in November 2023 as an Associate Consultant.
Nephelie holds a MEng in Chemical Engineering, with her dissertation research involving the fabrication of tissue engineering scaffolds for skin regeneration. She has additionally completed an MSc (Honours) in Nanotechnology and Regenerative Medicine from University College London (UCL), where she earned a spot on the dean’s list. Her research focused on exploring the role of borosilicate bioactive glasses in bone regeneration.
She has also pursued an MBA degree, enhancing her understanding and effectiveness in addressing complex healthcare challenges, conducting extensive pharmaceutical market analyses, and delivering strategic advice to pharmaceutical companies.
Prior to joining Eradigm, she worked as a Consultant at FTI Consulting, where she coordinated the company’s Data Analysis Initiative, gaining experience in implementing coding solutions for automating standard analysis methods. She has also acted as a Product Marketing Manager at a pioneering start-up company. Her tasks included the development of the go-to-Market strategy of the company, managing online marketing efforts, and closely monitoring the market landscape to gain insights on the current artificial skin therapies.
Outside of work, Nephelie stays active with yoga and cycling and is always eager to try out different fitness classes. She’s all about exploring the post-pandemic London scene, keeping an eye out for concerts, gigs, and dancing events”
Paula joined Eradigm in May 2022 as an Associate Consultant. With a keen interest in personalised medicine and novel therapies, Paula brings her experience in biomedical research to the team.
Paula holds an MSc in Engineering for Biomedicine from Imperial College London, where she researched new materials approaches for the detection and treatment of cancer. Prior to that, Paula completed her BSc in Human Biology from Pompeu Fabra University in Spain, where she took a multidisciplinary approach to learn about biomedical sciences and did her bachelor’s thesis on secretion pathways altered by colon cancer. During her BSc, Paula did an exchange programme at the Amsterdam University College in The Netherlands where she took global healthcare courses and developed her language skills.
Alongside her education, Paula spent time doing internships at the University of California San Diego, in the US, and at Sant Pau Hospital, in Spain, where she explored clinical and genetic approaches to diseases of the airways. These experiences in different cultures grew her ambition to use her life sciences knowledge for application approaches in an industry environment and led Paula to work on innovation strategies in between her studies.
Paula also believes in bringing scientific knowledge and education closer to those outside the science and medical communities and has worked and volunteered in Medical Information and Tutoring projects to increase accessibility in these areas.
Outside of work, Paula enjoys travelling, cooking, and music. She has a keen interest in combining these three hobbies and finding new ways of sharing them with other people.
Madina joined Eradigm as an Associate Consultant in July 2023, bringing her academic research experience and passion for Life Sciences industry to the team.
In her previous job Madina was conducting research and analysis of fine chemicals industry in the UK, working alongside world-class academics at Imperial College. She holds a Master’s degree with Distinction in International Health Management from Imperial College London, which provided her with commercial awareness and practical knowledge in health economics, business and marketing for healthcare and pharmaceutical companies.
Prior to this, Madina graduated from University College London with BSc Pharmacology, where she developed extensive knowledge and expertise in biomedicine and drugs. Her dissertation was focused on researching potential physiological targets for treatment of endothelial dysfunction, a type of non-obstructive coronary artery disease. Madina also completed an internship in consulting within sustainability, which encouraged her to pursue her career in consulting industry.
In her free time, Madina enjoys playing tennis, singing, exploring museums and hanging out with friends. She is also passionate about food and different cuisines, so cooking and baking provide her with space for creativity.
Bianka holds a First-Class Honours degree in business management from Queen Mary, University of London, where she studied the principles of economics, accounting, and organisational behavior.
A year spent at Cornell University as an exchange student further enriched her academic palette, exposing her to subjects like cognitive science, ethical decision-making in management, and negotiations. Transitioning into the world of data, Bianka pursued her first master’s degree in Data Science with Bioinformatics at the University of Durham. While her coursework covered practical applications of computational methodologies, her independent research focused on critically evaluating the ethical implications of emerging AI-enabled technologies. This technical foundation seamlessly transitioned into her second master’s degree, an MPhil in Translational Neuroscience at the University of Cambridge. Here, she led a computational psychiatry project, employing machine learning models to predict autism spectrum disorders from prenatal data. Alongside this, she developed a deep interest in nutritional psychiatry and the microbiome’s crucial role in health.
Bianka also participated in an external consulting project with an NGO, where she was tasked with identifying key demographic trends and donor behaviours with regards to charitable giving.
Outside of work, she enjoys playing sports, especially tennis and golf. She also likes taking long walks in different London neighbourhoods and often stops for an iced coffee during her strolls.
Tiya joined Eradigm in July 2023 as an Associate Consultant, bringing to the team her passion for advancing healthcare research and prior experiences working in PR, medical communications, and digital health start-ups.
Previously, Tiya was a PR consultant managing several pharmaceutical clients and various projects, spanning therapeutic areas including neurology, immunology, orthopaedics, dermatology, and women’s health. Tiya was involved in advising clients with their communications strategy during key congresses, on data communications and competitive insights, developing high-quality HCP and patient materials, and managing relationships with patient advocacy groups and multiple external stakeholders.
Tiya holds a BSc in Biological Sciences from the University of Leicester, where she studied Neuroscience and focused her dissertation and research interests in maternal health and child neurodevelopment. Tiya studied for her MSc at University College London (UCL), in Bioscience Entrepreneurship, where she developed her expertise in the intersection between life sciences and research commercialisation. During her post-graduate studies, Tiya worked at digital health start-ups which intend to disrupt and transform standard healthcare and medicine, through innovations in digital technology. At Syrona Health, spinout FemTech company from University of Cambridge, Tiya developed an in-app digital tool for personalised contraception with a focus on limiting side effects. Tiya was also part of the 2021 Entrepreneur In Residence cohort for idea incubation in European healthcare, with SanusX UNIQA, a leading insurance provider in CEE.
From her experiences in medical communications, working at MedTech startups, and her studies, Shakitiya hopes to continue expanding her knowledge in the fields of entrepreneurship, science communication, healthcare and research.
Outside of work, Tiya likes to keep active with weight-lifting, salsa-dancing, Muay Thai, and swimming. Passionate about exploring new cultures, Tiya enjoys travelling around the world, meeting new people, and experiencing local cuisines.
Megan joined Eradigm in August 2023 as an Associate Consultant, bringing an interest in transformative technologies for improving healthcare and research experience ranging from regenerative medicine to digital health technologies.
Megan has a BSc in Biological Sciences (Biotechnology) from the University of Edinburgh, where she studied medical, agricultural, molecular, and industrial biotechnology. Her dissertation focused on the development of hydrogels for tissue engineering. Megan then studied for an MPhil in Bioscience Enterprise at the University of Cambridge. This multidisciplinary biotech and business course focused on teaching strategy, healthcare economics, venture financing and valuations, intellectual property, and trends in biotechnology. It included an external consulting project with an AI drug discovery start-up, where Megan was tasked with identifying the current trends in small-molecule combination therapy deals. Megan also worked with a digital health start-up for her final dissertation. Her dissertation investigated ADHD Care in the Digital age, identifying the market and demand for children’s digital health technologies. This research aimed to advise the start-up on key risks and interest areas in digital ADHD Care. Megan looks forward to expanding her knowledge of entrepreneurship and the regulatory process for novel technologies.
In her free time, Megan enjoys running, going to the gym, visiting museums and galleries, and spending time with friends. She also enjoys trying new coffee shops and pastries.
Eleanor joined Eradigm as an Associate Consultant in September 2023, bringing with her experience in market research and a passion for healthcare. In her previous role, she focused on health economics, project management, and primary and secondary research for large pharmaceutical companies and small biotech. Eleanor has experience utilising a breadth of research techniques to help support clients’ submissions to HTA bodies and product lifecycle management.
Eleanor holds a BSc Honours in Pharmacology from The University of Southampton. During this programme, she evaluated the potential of a new disease-modifying treatment for Alzheimer’s Disease. Eleanor’s interest and passion for healthcare systems and pharmaceutical development led her to purse a MSc in Pharmaceutical Formulation and Entrepreneurship at UCL. In her MSc dissertations, she formulated a 3D printed multi-drug-loaded suppository for the treatment of acute severe ulcerative colitis in addition to assessing its commercial feasibility in a business case analysis. As a result, Eleanor has become passionate about the development of personalised medicines and processes to support the efficiency of healthcare systems.
Outside of work, she is an avid runner and frequent gym-goer who loves to run to new coffee and pastry shops on the weekend and will always try and persuade others to join her. In her free time, she also enjoys cooking, spending time with friends and exploring new places.
Estela joined Eradigm in September 2023 as an Associate Consultant, bringing her enthusiasm for aiding healthcare companies in advancing and commercializing therapies, coupled with her professional and academic achievements in the life sciences.
Previously, Estela worked at GLG, supporting multiple clients across the pharmaceutical and diagnostic industries to connect with key experts and stakeholders across the product lifecycle. Here, Estela built commercial and industry knowledge, by working on projects across multiple therapeutic areas and stages of development.
Estela holds a BSc in Biomedical Sciences from University College London, which included a neuroscience research project, specifically on the molecular programming of MGE-derived cortical interneurons. Estela also holds an MSc in Genes, Drugs, and Stem Cells – Novel Therapies from Imperial College London, where she explored the cell and gene therapy landscape, and conducted research on the role of key miRNAs in ischaemic heart disease and diabetes.
From her experience at GLG and university degrees, Estela hopes to get one step closer to supporting healthcare clients with product commercialisation, and helping patients get access to treatments.
In her free time, Estela enjoys sewing, reading, listening to true crime podcasts, swimming, and going to the gym.
Chloe joined Eradigm in January 2025 as an Associate Consultant, bringing her experience in healthcare market research, an MSci Neuroscience degree, and a passion for strategic problem-solving in the life sciences.
She brings expertise in healthcare market research, behavioural science, and an MSci in Neuroscience. Through market research, she has gained experience across multiple therapeutic areas, including oncology, neurology, and endocrinology.
Chloe holds an integrated Master’s degree in Neuroscience from the University of Southampton, where she specialised in oncology, biochemistry, and bioinformatics. Her academic achievements include two dissertations: one using CRISPR/Cas9 to study the role of beta-catenin in cancer treatment, and another employing bioinformatics to identify E3-ligases implicated in hippocampal degradation related to neurodevelopmental disorders such as autism, ADHD, and schizophrenia. Alongside her studies, she pursued a French language module and participated in business competitions, where she successfully pitched innovative ideas to expert panels.
Outside of work, Chloe enjoys weightlifting at the gym, songwriting, Bible studies with her church group, and travelling to explore new cultures.
Diana joined Eradigm in January 2025 as an Associate Consultant, driven by her passion for bringing innovative therapies to the market. With a strong scientific background and diverse business experience, she is skilled at bridging the gap between science and the market, identifying opportunities, assessing risks, and providing market access insights.
Before joining Eradigm, Diana worked as a Venture Capital Fellow at the London Venture Capital Network, gaining expertise in the life sciences startup ecosystem. She evaluated startups through scientific and commercial due diligence and provided competitive analysis to support investment decisions, all while building professional relationships at the partner level. Diana has also worked as a Consultancy Project Manager at London Healthcare Insights, leading market and health economic research on health technologies in UK retail pharmacies and virtual wards, while advising clients on regulatory pathways. Her extensive research background includes a role as a Research Assistant at University College London, where she collaborated with Dr Maryam Parhizkar on tissue-engineered vascular grafts. Diana contributed to refining formulations through primary and secondary research, co-authored research findings with PhD students, and supervised an MSc dissertation on drug-loaded vascular grafts.
Diana holds a BSc in Clinical and Community Pharmacy from Bandung Institute of Technology and is a licensed pharmacist. During her placements, Diana was exposed to product lifecycle management, pricing, and reimbursement strategies. Her interest in the business side of life sciences led her to pursue an MSc in Pharmaceutical Formulation and Entrepreneurship at University College London, graduating with distinction and earning a place on the Dean’s List. There, she gained hands-on experience in nanoformulation for rare diseases, startup due diligence, financial modelling, and evaluating the commercial potential of healthcare innovations. For her dissertations, Diana developed a tissue-engineered vascular graft for hemodialysis and assessed its commercial viability.
Outside of work, Diana enjoys staying active with lagree megaformer, reformer pilates, and boxing. She is also a big fan of matcha and loves weekend bakery runs with her friends.
Suruchi joined Eradigm as an Associate Consultant in September 2024, driven by her passion for supporting healthcare innovation and bringing new therapies to market.
With a PhD in Biochemistry from the Max Planck Institute of Molecular Physiology, she explored the intricacies of cell cycle regulation, focusing on how cells ensure accurate chromosome separation by accelerating the formation of the Mitotic Checkpoint Complex (MCC). Her research employed an in vitro setup to recreate the cellular machinery, revealing how specific proteins expedite MCC formation at the kinetochores, ensuring efficient and error-free cell division.
Combining her scientific expertise with practical experience, she immersed herself in London’s vibrant startup ecosystem by joining the Innovation Forum as a Programme Coordinator. In this role, she fostered connections among a network of over 10,000 investors, academics, and startups, and coordinated events focused on the latest healthcare innovations. To deepen her understanding of healthcare trends and the challenges faced by entrepreneurs, she also joined the Science Entrepreneur Club as a Science Writer, engaging with founders in life sciences to uncover the unique aspects of their startups and showcase their journeys.
Outside of work, she enjoys winding down with a good book and a great cup of coffee and is committed to building a habit of practicing yoga and going to the gym.
Sofia joined Eradigm in September 2024 as an Associate Consultant, after joining us as an Intern in 2023, bringing her diverse background in neurodegenerative diseases and stem cell biology, along with a passion for advancing the Life Sciences industry.
Sofia completed a PhD in Advanced Therapies for Regenerative Medicine at King’s College London, where her research explored the role of neuroinflammation in ALS. During her studies, she collaborated with leading academic institutions, including The Francis Crick Institute and received several grants and awards for her work. In addition to her academic experience, Sofia gained valuable industry insights as a Venture Associate at a venture capital firm, evaluating start-ups and technologies in AI and neuroscience. Sofia has also completed a course at London Business School, where she developed skills in business strategy and leadership, further strengthening her ability to bridge the gap between science and business.
Outside of work, Sofia enjoys art, theatre, visiting museums and discovering new cultures. She is also actively involved in mentorship, guiding and empowering young women pursuing careers in STEM.
Sarah joined Eradigm in September 2024 as an Associate Consultant, driven by her passion for supporting healthcare and pharmaceutical companies in strategising, advancing, and commercialising innovative therapies. With a strong academic foundation and valuable professional experience, she is excited to contribute to Eradigm’s mission and thrive in her consulting career.
Before joining Eradigm, Sarah worked at Guidepoint, where she supported clients across the pharmaceutical and healthcare sectors by connecting them with key industry experts. Here she developed broad commercial and industry insights, as she collaborated with a diverse range of clients in the Healthcare sector. Prior to this, Sarah worked in recruitment as a Talent associate and advanced quickly to Senior Talent Associate, specialising in executive-level recruitment. She collaborated closely with global directors, driving recruitment strategies that exceeded organisational goals.
Sarah holds a BSc in Medical Physiology from the University of Leicester, where she graduated with a First Class Honours. Her dissertation focused on the bioethical analysis of egg freezing in the UK, for which she earned a First Class. Additionally, she worked on a project mapping the complex progression of cancer, exploring aspects such as monoclonal origin and tumour heterogeneity, for which she was awarded top performance in the module. Sarah has just completed her MSc in Biotech and Pharmaceutical Management at University College London (UCL), where she was awarded two prestigious scholarships: the UCL East London Scholarship and the Global Business School for Health Women Healthcare Leaders Scholarship. Her research project focused on evaluating factors affecting medication adherence to anti-diabetic medication among patients in Nigeria.
Additionally, during her time at UCL, Sarah collaborated with a team on a business project to develop an innovative hydrogel wound dressing, designed with unique properties to improve the treatment of diabetic foot ulcers. Together, the team crafted a detailed business proposal highlighting the product’s commercial viability and market potential, further demonstrating Sarah’s ability to blend scientific expertise with strategic business acumen.
Outside of work Sarah enjoys travelling, eating out, reformer pilates, Sunday church services, and unwinding by watching the real housewives!
Auxtine joined Eradigm in September 2024 as an Associate Consultant. She holds a PhD in Precision Oncology from University College London (UCL).
Her work involved bioengineering 3D in vitro tumour models, which served as testing platforms for mechano-based cancer therapies. Auxtine is well published, with four first-author publications in high-impact, peer-reviewed journals, as well additional second author publications. During her time at UCL, she won multiple awards, including a nomination to join annual Nobel Laureates gathering, as an outstanding young scientist. She also holds a MEng and a BEng in Biomedical Engineering from Imperial College London.
Prior to joining Eradigm, she worked as a senior scientist at an investor-backed biotech start-up, where she was in charge of building a regenerative medicine programme using novel adult multi-potent stem cells. There she was also involved in commercial development, growth strategy, patent applications, and fundraising.
Outside of work, Auxtine enjoys reformer pilates classes, reading, walks in the parks, and trying out new coffee shops, wine bars and restaurants with friends.
Samuel joined Eradigm in January 2025 as an Associate Consultant, bringing experience in early stage life sciences research, venture capital investment, and entrepreneurship.
Following a Physics BSc at the University of Bath, where his research focused on computational neuron models, Samuel was awarded a distinction for his MSc in Biological Physics at UCL. There, he built a computational model of cancer mutations whilst simultaneously working as a research assistant at a pharmaceutical startup and founding a student-led think tank centred on bioethics and medical law.
Most recently, Samuel completed his PhD at the world leading neutron source, L’Institut Laue Langevin, in collaboration with AstraZeneca and the University of Manchester. His research focused on the nucleic acid delivery vehicle used in the Pfizer/Moderna COVID-19 vaccine. During the final year of his PhD, Samuel gained valuable insights as a Venture Associate at the AIxBio venture capital fund, Next Sequence, where he evaluated startups and technologies in the space-based life sciences vertical.
Outside of work, Samuel enjoys spending time reading literature with a philosophical theme, swimming, exploring new cafés, and going to art exhibitions. His favourite travel story is his three month solo-backpacking trip across China.
Antonio joined Eradigm in January 2025 as an Associate Consultant. He holds a PhD in Molecular Immunology from UCL, where his research focused on the impact of IL-10 family cytokines and microbial metabolites on intestinal permeability. His work included in vitro assessments of epithelial permeability, proliferation, apoptosis, and wound healing, as well as analysing intestinal permeability and cytokine profiles in patients undergoing haematopoietic stem cell transplantation compared to healthy controls.
Prior to his PhD, Antonio contributed to the optimisation of a UCL-patented lentiviral vector for clinical applications as a research assistant. He also gained significant experience as a pharmacist, managing multiple community pharmacies and clinics, which honed his leadership skills and business acumen.
Outside of work, Antonio enjoys practising Brazilian Jiu-Jitsu, exploring new restaurants and theatres and enjoys fishing whenever the opportunity arises.
Sufaanah joined Eradigm as an Associate Consultant in January 2025, bringing expertise in life sciences and commercial strategy to the team. She is passionate about leveraging her scientific expertise and commercial experience to deliver impactful solutions in the Life Sciences industry.
She holds a PhD in Cardiovascular Regenerative Medicine from the Royal Veterinary College (RVC), where her research focused on developing an innovative method to enhance the cardioprotective effects of stem cells, optimising their therapeutic potential for heart disease. During this time, she actively contributed to the broader scientific and public health community, which included participating in the COVID National Asymptomatic Testing Programme at the RVC testing site, supporting efforts to mitigate the spread of infection during the pandemic.
She has been awarded multiple research grants in recognition of her work. Her academic background also includes an MSc from King’s College London, MRes from University College London and BSc from the University of Leicester.
Prior to joining Eradigm, she gained commercial experience working at an insurance firm, where she played a key role in commercial development and growth strategy. She identified opportunities for business growth, implemented strategies to enhance operational efficiency, and collaborated with cross-functional teams to deliver measurable results. These experiences equipped her with a robust understanding of commercial strategy and the ability to transform data-driven insights into actionable plans—skills she now applies to her work at Eradigm.
Outside of work, she enjoys reading, cooking, exploring new restaurants, taking walks in the park, and Pilates.
Core Services Team
Focus areas
All financial aspects of Eradigm. Among other things, this includes ensuring appropriate controls and processes are in place to enable the business to function effectively, business planning and analysis to support decision-making and leading the Eradigm Finance Team. I provide strategic guidance, insight and reassurance to the Eradigm Leadership Team.
Specialist expertise
I’m a qualified accountant and a member of the Association of Chartered Certified Accountants. My background is very commercial, so I’m experienced in planning and analysis, forecasting, budgeting and management reporting and cashflow reporting and management. I also have extensive experience in dealing with technical accounting matters, including statutory reporting and audit.
Education
Bachelor’s Degree in Accounting and Finance from the University of Brighton. ACCA qualified accountant.
What is your focus at Eradigm?
Ensuring that all financial aspects of the business are managed effectively. This includes providing clear information for decision-making in a way which can be readily understood by both financial and non-financial users. I see my role as making sure that “everything is working as it should” and providing recommendations, support and guidance on potential areas for improvement.
I also ensure that all finance-related statutory requirements are met, including annual accounts, tax compliance and audit.
Who do you work with?
The Finance Team is an integral part of the Eradigm business – we support, analyse and challenge across all areas where we feel we can make a positive impact.
My primary contacts are the Partners and Senior Management Team – providing them with relevant financial insights and recommendations to help the business to be as successful as possible.
What did you do before Eradigm?
My career as a finance professional spans over 20 years across a diverse range of businesses, from fine art to high-end retail to leisure and hospitality.
Prior to joining Eradigm, I was the Finance Director for a UK based hotel Group – my experience included managing all financial aspects of the difficulties associated with the Covid-19 pandemic, enabling the businesses to bounce back strongly when conditions eventually returned to normal.
What are your passions outside of work?
During the summer of 2021, I achieved a long-term goal to become a Qualified Personal Trainer. I enjoy all aspects of fitness and health and am regularly at the gym. Being from Cornwall, I also enjoy trail running on the coastal paths and open-water swimming, which I combine with beach-time whenever I’m able to.
Education:
BSc in Chemistry from University of Birmingham.
Management Accounting and Reporting
What is your focus at Eradigm?
My main focus at Eradigm is to streamline the financial processes to cope with the tremendous growth the company has experienced. I am also responsible for month-to-month cashflow, accounts payable and invoice scheduling.
Who do you work with?
I work closely with the financial controller of Eradigm to help maintain the monthly management accounts and reports for the partners.
What is your specialist expertise, and what types of projects do you work on?
My main expertise is that I am analytically minded and as a result, most of my projects will involve reconciliations and problem solving and ensuring all financial data is accurate. I have also had previous experience with systematic reviews to improve the efficiency of the finance team, my attention to detail is crucial for my project involvement.
What did you do before Eradigm?
Prior to working at Eradigm, I have had experience in the fintech industry, as well as the fine art/auction industry. All my previous roles have provided me with excellent financial acumen and skills.
What are your passions outside of work?
I am actively studying for my CIMA accountancy exams. I am a huge sports fan and I am always looking for a new and exciting sport to get involved in. I am also passionate about food and pub quizzes.
Education:
After completing my A-Levels, I went straight into employment. My career in a finance-related environment started 4 years ago, where I trained as a Bookkeeper and Payroll Administrator in an Accounting Firm. Throughout my career, I studied and gained my Level 2 AAT Foundation Certificate in Bookkeeping.
What is your focus at Eradigm?
My focus at Eradigm is to learn about the financial processes of the company and provide finance support. Throughout the years, I have developed a very keen interested in finance and I am very much looking forward to developing my career within this department.
What did you do before Eradigm?
Prior to joining at Eradigm, I was working as a counter assistance in a pharmacy for three to four years. When I decided if it was not for me, I left the job and started working for an accountant firm based in Coulsdon. Then I left the firm to focus more on payroll, where I worked sorely as a payroll administrator.
What are your passions outside of work?
My passion outside of work is spending my time with my loved ones. I also enjoy learning new subjects such as different philosophies, writing and art! As boring as it sounds, I am the type of person that can spend hours in a museum. But also enjoy more “fiery” activities such as traveling, yoga, paintballing & playing my PlayStation (If that counts)…
Originally from Poland, Natalia built her career in operations after moving to the UK, gaining experience in various roles, from supervising a fashion brand to managing office spaces, before stepping into her leadership role at Eradigm.
Natalia joined Eradigm in 2023 and leads operations across Finance, HR, and Partner support. She plays a key role in ensuring the smooth running of day-to-day business functions while continuously identifying opportunities to improve efficiency and maximize return on investment. As a central support to the wider team of consultants, she streamlines processes and enhances operational effectiveness.
Outside of work, she enjoys drawing and spending time with her Cocker Spaniel puppy, Guinness, who has quickly become an honorary member of the Eradigm team.
My focus here at Eradigm is to contribute to the success of the business and, of course, it’s employees. As well as this, being a key point of contact, problem solving and creating a thriving working environment for all is what I aim to achieve.
Who do I work with?
I work side by side with the HR Director, the Operations Team and the Finance Team.
What did I do before Eradigm?
My career in HR started in 2022 after graduating with a Psychology degree from Coventry University, when I joined a data consulting firm as HR Assistant.
In my short career so far, I’m lucky to have been exposed to many processes such as training, benefits, probation, improving company culture and employment policies and procedures. Having been half of the HR team since I started my career, I’ve adopted an ‘all hands-on deck’ personality, enabling me to be everywhere at once, whilst producing high quality and accurate work.
What are your passions outside of work?
Recently, I went on a solo trip to Dubai for 10 days and it’s safe to say that won’t be my last! My aim is to solo-travel at least once a year. Additionally, I love hairdressing and I have done since I was young. Lastly, I love serving in my church!
Our Values
Values are what make a business successful, unique, long-lasting – and what allows Eradigm to attract outstanding professionals to be a part of our team.
What Eradigm stands for as a business covers many areas. At our core, we uphold the principles of integrity, innovation, and a relentless pursuit of excellence. These fundamentals guide us in delivering meaningful solutions and fostering sustainable growth in all that we do. Take a look below at how our values shape our work:
Drive Excellence
Embracing challenges is fundamental to our corporate ethos, driving us to revolutionize, adapt, and achieve excellence in every endeavor we pursue
Nature Partnerships
Our corporate strength lies in cultivating enduring relationships with clients, fostering collaboration, trust, and mutual success at every level
Celebrate Diversity
At Eradigm, we recognize that diversity of experience, thought and background, enriches our culture and our services, bringing drive innovation and transformative engagements
Leave a Legacy
Dedicated to leaving a profound legacy in the life sciences sector, contributing to pioneering innovations that shape the future of healthcare and improve the well-being of patients
Contact information
Fill in the contact form and a member of your team will get back to you
info@eradigm.com
Eradigm Consulting
Work.Life
6-7 St Cross St,
London, EC1N 8UB
